Lista de obras -

A Cluster of Patients Infected With I221V Influenza B Virus Variants With Reduced Oseltamivir Susceptibility—North Carolina and South Carolina, 2010–2011 ⬇️

artículo científico publicado el 13 de diciembre de 2012

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

artículo científico publicado en 2008

Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.

artículo científico publicado en 2013

Bioluminescence-Based Neuraminidase Inhibition Assay for Monitoring Influenza Virus Drug Susceptibility in Clinical Specimens ⬇️

artículo científico publicado el 5 de agosto de 2013

Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment

artículo científico publicado en 2013

Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States

artículo científico publicado en 2011

Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

artículo científico publicado en 2014

Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro ⬇️

artículo científico publicado el 1 de enero de 2010

Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance

artículo científico publicado en 2014

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289.

artículo científico publicado en 2011

Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors

artículo científico publicado en 2008

Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013

artículo científico publicado en 2015

Detection of an Influenza B Virus Strain with Reduced Susceptibility to Neuraminidase Inhibitor Drugs ⬇️

artículo científico publicado el 7 de septiembre de 2011

Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins

artículo científico publicado en 2017

Drug resistance mutations among South African children living with HIV on WHO-recommended ART regimens

artículo científico publicado en 2020

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria

artículo científico publicado en 2013

Early Diagnosis of HIV Infection in Infants - One Caribbean and Six Sub-Saharan African Countries, 2011-2015.

artículo científico publicado en 2016

High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019

artículo científico publicado en 2020

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses

artículo científico publicado en 2009

Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011.

artículo científico publicado en 2012

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses

artículo científico publicado en 2010

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11 ⬇️

artículo científico publicado el 1 de noviembre de 2011

Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.

artículo científico publicado en 2009

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective ⬇️

artículo científico publicado el 13 de octubre de 2010

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.

artículo científico publicado en 2013

Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir ⬇️

artículo científico publicado el 23 de diciembre de 2012

Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route

artículo científico publicado en 2011

Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative survey

artículo científico publicado en 2020

Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

artículo científico publicado en 2016

R292K substitution and drug susceptibility of influenza A(H7N9) viruses

artículo científico publicado en 2013

Regulation of Viral RNA Synthesis by the V Protein of Parainfluenza Virus 5

artículo científico publicado en 2015

Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.

artículo científico publicado en 2017

Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease

artículo científico publicado en 2009

The C, V and W proteins of Nipah virus inhibit minigenome replication

artículo científico publicado en 2008

The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses

artículo científico publicado en 2013

The polymerase (L) protein of rinderpest virus interacts with the host cell protein striatin

artículo científico publicado en 2005

Lista de obras de

A Cluster of Patients Infected With I221V Influenza B Virus Variants With Reduced Oseltamivir Susceptibility—North Carolina and South Carolina, 2010–2011 ⬇️

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.

Bioluminescence-Based Neuraminidase Inhibition Assay for Monitoring Influenza Virus Drug Susceptibility in Clinical Specimens ⬇️

Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment

Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States

Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro ⬇️

Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289.

Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors

Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013

Detection of an Influenza B Virus Strain with Reduced Susceptibility to Neuraminidase Inhibitor Drugs ⬇️

Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins

Drug resistance mutations among South African children living with HIV on WHO-recommended ART regimens

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria

Early Diagnosis of HIV Infection in Infants - One Caribbean and Six Sub-Saharan African Countries, 2011-2015.

High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chókwè Health Demographic Surveillance System, Mozambique, 2014-2019

Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses

Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011.

In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11 ⬇️

Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers.

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective ⬇️

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.

Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir ⬇️

Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route

Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative survey

Progress with Scale-Up of HIV Viral Load Monitoring - Seven Sub-Saharan African Countries, January 2015-June 2016.

R292K substitution and drug susceptibility of influenza A(H7N9) viruses

Regulation of Viral RNA Synthesis by the V Protein of Parainfluenza Virus 5

Returning HIV-1 viral load results to participant-selected health facilities in national Population-based HIV Impact Assessment (PHIA) household surveys in three sub-Saharan African Countries, 2015 to 2016.

Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease

The C, V and W proteins of Nipah virus inhibit minigenome replication

The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses

The polymerase (L) protein of rinderpest virus interacts with the host cell protein striatin